Advisa MRI™ SureScan® Pacemaker
Second generation SureScan® pacemaker provides leading-edge pacing technology that can be used safely in a MRI environment.
What should you expect in today’s leading-edge pacing system? A system that can benefit patients tomorrow as well.
The Advisa MRI™ pacing system is designed for safe access to MRI diagnostic imaging with SureScan® and unparalleled disease insight and management for your patients today. Plus it has the tools to diagnose and manage the co-morbidities they may develop tomorrow. Our most advanced Advisa MRI™ pacing system provides your patients unsurpassed capabilities. Innovative features like MVP®, OptiVol®, digital diagnostics and a complete suite of atrial therapies.
Innovation. Sophistication. Simplicity. With no compromise.
SureScan® is designed for safe access to MRI, an unparalleled diagnostic imaging
For millions of patients with cardiac devices, MRI scans are unsafe and contraindicated. 50%–75% of patients with an implantable cardiac device will need an MRI scan over the lifetime of their device. SureScan® pacing systems are the first pacing systems — consisting of the pacemaker and leads — that are designed, tested, and CE Mark-approved for full body MRI scans when used according to labeling.
Managed Ventricular Pacing (MVP®)
Unnecessary right ventricular (RV) pacing increases the risk of Atrial Fibrillation (AF), Heart Failure hospitalisation, and mortality. The ESC Guidelines state that in the selection of pacing mode and device, “the trend is towards dual chamber pacing with minimisation of right ventricular stimulation” and the ACC/AHA/HRS guidelines also recognised the importance of minimising unnecessary RV pacing. Managed Ventricular Pacing (MVP®) is proven to reduce unnecessary RV pacing by 99%.13
Full Automaticity — proven safe, simple, and accurate
Fully automatic pacemaker follow-up means more time with patients, less time with devices. Atrial and Ventricular Capture Management™ (ACM and VCM) provide confidence in your patients’ safety with automatic threshold measurements and adjustments. TherapyGuide® offers easy, patient tailored nominal programming.
Cardiac Compass® Trends provide clear information for detecting atrial arrhythmias and for rapid decision making.
22 minutes of dual channel high quality stored EGM.
OptiVol® Fluid Status Monitoring tracks and monitors fluid changes using intrathoracic impedance measurements.
Carelink® Network allows remote device follow-up by transmitting comprehensive arrhythmia and diagnostic data right to your clinic.
Atrial tachyarrhythmia tools help in the early detection and management of AF.
Rate Drop Response identifies abrupt cardiac slowing and responds by pacing the heart at an elevated rate.
High Upper Tracking Rates up to 210 bpm are beneficial for your pediatric patients as well as young and active patients.
Brochure
Advisa MRI™ Overview Brochure
Manuals
In addition to the CapSure Fix MRI™ SureScan® active fixation lead (Model 5086MRI), the CapSure Sense MRI™ SureScan® passive fixation leads (Model 4074 - 52 and 58 cm lengths and Model 4574 - 45 and 53 cm lengths) have been approved for MR-conditional use in certain geographies. The MRI procedural manual in these geographies has been updated to include the passive fixation leads. Therefore to choose the manual appropriate for your country please complete the following steps:
- Click on this link to determine if your country has received approval for the MR-conditional passive fixation leads.
- If your country has received approval for the MR-conditional passive fixation leads, click here for the updated MRI procedural manual
- If your country has not received approval for the MR-conditional passive fixation leads, click here for the MRI procedural manual
